82 related articles for article (PubMed ID: 35659579)
21. Sexually transmitted diseases: incidence and distribution.
Wang Q
Chin Med Sci J; 1996 Mar; 11(1):56-62. PubMed ID: 9206122
[TBL] [Abstract][Full Text] [Related]
22. Impact of COVID-19 pandemic on the epidemiology of STDs in China: based on the GM (1,1) model.
Yan J; Li Y; Zhou P
BMC Infect Dis; 2022 Jun; 22(1):519. PubMed ID: 35659579
[TBL] [Abstract][Full Text] [Related]
23. Trends in the Epidemiology of Sexually Transmitted Disease, Acquired Immune Deficiency Syndrome (AIDS), Gonorrhea, and Syphilis, in the 31 Provinces of Mainland China.
Ye X; Liu J; Yi Z
Med Sci Monit; 2019 Jul; 25():5657-5665. PubMed ID: 31361737
[TBL] [Abstract][Full Text] [Related]
24. The Epidemic of Sexually Transmitted Diseases Under the Influence of COVID-19 in China.
Yan X; Wang X; Zhang X; Wang L; Zhang B; Jia Z
Front Public Health; 2021; 9():737817. PubMed ID: 34976912
[No Abstract] [Full Text] [Related]
25. A long trend of sexually transmitted diseases before and after the COVID-19 pandemic in China (2010-21).
Xu A; Zuo Z; Yang C; Ye F; Wang M; Wu J; Tao C; Xun Y; Li Z; Liu S; Huang J
Sex Health; 2023 Dec; 20(6):497-505. PubMed ID: 37649382
[TBL] [Abstract][Full Text] [Related]
26. Development and comparison of predictive models for sexually transmitted diseases-AIDS, gonorrhea, and syphilis in China, 2011-2021.
Zhu Z; Zhu X; Zhan Y; Gu L; Chen L; Li X
Front Public Health; 2022; 10():966813. PubMed ID: 36091532
[TBL] [Abstract][Full Text] [Related]
27. Epidemiologic trends of sexually transmitted diseases in China.
Chen XS; Gong XD; Liang GJ; Zhang GC
Sex Transm Dis; 2000 Mar; 27(3):138-42. PubMed ID: 10726645
[TBL] [Abstract][Full Text] [Related]
28. Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants.
Wang Z; Zhao Z; Cui T; Huang M; Liu S; Su X; Li G; Song T; Li W; Zhong N; Xu M; Yang X; Huang W
Emerg Microbes Infect; 2022 Dec; 11(1):829-840. PubMed ID: 35230230
[TBL] [Abstract][Full Text] [Related]
29. Vaccinations, Mobility and COVID-19 Transmission.
Guo J; Deng C; Gu F
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010357
[TBL] [Abstract][Full Text] [Related]
30. Mobile Apps Leveraged in the COVID-19 Pandemic in East and South-East Asia: Review and Content Analysis.
Lee B; Ibrahim SA; Zhang T
JMIR Mhealth Uhealth; 2021 Nov; 9(11):e32093. PubMed ID: 34748515
[TBL] [Abstract][Full Text] [Related]
31. HIV and COVID-19: review of clinical course and outcomes.
Barbera LK; Kamis KF; Rowan SE; Davis AJ; Shehata S; Carlson JJ; Johnson SC; Erlandson KM
HIV Res Clin Pract; 2021 Aug; 22(4):102-118. PubMed ID: 34514963
[No Abstract] [Full Text] [Related]
32. Modeling analysis reveals the transmission trend of COVID-19 and control efficiency of human intervention.
Cheng C; Wan X; Zhang Z
BMC Infect Dis; 2021 Aug; 21(1):849. PubMed ID: 34418983
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study.
Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y
BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697
[TBL] [Abstract][Full Text] [Related]
34. Short-term prediction of COVID-19 spread using grey rolling model optimized by particle swarm optimization.
Ceylan Z
Appl Soft Comput; 2021 Sep; 109():107592. PubMed ID: 34121965
[TBL] [Abstract][Full Text] [Related]
35. Nationwide study on trends in unplanned hospital attendance and deaths during the 7 weeks after the onset of the COVID-19 pandemic in Denmark.
Bogh SB; Fløjstrup M; Nissen SK; Hanson S; Bech M; Johnsen SP; Kristensen MR; Laugesen LE; Søndergaard J; Folkestad L; Christensen EF; Henriksen DP; Hsia RY; Graham CA; Lindskou TA; Byg KE; Søvsø MB; Laugesen H; Hallas P; Mikkelsen S; Olsen KR; Thygesen LC; Gamst-Jensen H; Brabrand M
BMJ Qual Saf; 2021 Dec; 30(12):986-995. PubMed ID: 33952687
[TBL] [Abstract][Full Text] [Related]
36. The Impact of the COVID-19 Pandemic on Sexually Transmitted Infection/Human Immunodeficiency Virus Testing Among Adolescents in a Large Pediatric Primary Care Network.
Bonett S; Petsis D; Dowshen N; Bauermeister J; Wood SM
Sex Transm Dis; 2021 Jul; 48(7):e91-e93. PubMed ID: 33783411
[TBL] [Abstract][Full Text] [Related]
37. STIs during the first and second wave of COVID-19 in Denmark.
Heerfordt IM
Sex Transm Infect; 2022 Mar; 98(2):150-151. PubMed ID: 33737449
[No Abstract] [Full Text] [Related]
38. Impact of COVID-19 pandemic on STIs in Greece.
Apalla Z; Lallas A; Mastraftsi S; Giannoukos A; Noukari D; Goula M; Kalantzi P; Zapridou M; Lallas K; Kyrgidis A; Lazaridou E; Stratigos A; Sidiropoulos T; Nicolaidou E
Sex Transm Infect; 2022 Feb; 98(1):70. PubMed ID: 33653880
[No Abstract] [Full Text] [Related]
39. Sexually transmitted diseases during the COVID-19 pandemic: A focus on syphilis and gonorrhoea in Cuba.
Rodríguez I; Hernández Y
Public Health Pract (Oxf); 2021 Nov; 2():100072. PubMed ID: 33521735
[TBL] [Abstract][Full Text] [Related]
40. The Impact of COVID-19 on Sexual Health: A Preliminary Framework Based on a Qualitative Study With Clinical Sexologists.
Pascoal PM; Carvalho J; Raposo CF; Almeida J; Beato AF
Sex Med; 2021 Feb; 9(1):100299. PubMed ID: 33482611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]